Drugmaker slashes US price of weight-loss therapy
Novo Nordisk has halved the US price of its weight‑loss drug, a move aimed at broadening access amid strong demand and competition in the GLP‑1 market.
Tag
Us Price
All articles tagged with #us price
All articles tagged with #us price
Novo Nordisk has halved the US price of its weight‑loss drug, a move aimed at broadening access amid strong demand and competition in the GLP‑1 market.